Literature DB >> 31719150

Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments.

Yasna Contreras-Baeza1, Pamela Y Sandoval1, Romina Alarcón1,2, Alex Galaz1, Francisca Cortés-Molina1, Karin Alegría1, Felipe Baeza-Lehnert1,2, Robinson Arce-Molina1,2, Anita Guequén1, Carlos A Flores1, Alejandro San Martín3, L Felipe Barros4.   

Abstract

Monocarboxylate transporter 4 (MCT4) is an H+-coupled symporter highly expressed in metastatic tumors and at inflammatory sites undergoing hypoxia or the Warburg effect. At these sites, extracellular lactate contributes to malignancy and immune response evasion. Intriguingly, at 30-40 mm, the reported Km of MCT4 for lactate is more than 1 order of magnitude higher than physiological or even pathological lactate levels. MCT4 is not thought to transport pyruvate. Here we have characterized cell lactate and pyruvate dynamics using the FRET sensors Laconic and Pyronic. Dominant MCT4 permeability was demonstrated in various cell types by pharmacological means and by CRISPR/Cas9-mediated deletion. Respective Km values for lactate uptake were 1.7, 1.2, and 0.7 mm in MDA-MB-231 cells, macrophages, and HEK293 cells expressing recombinant MCT4. In MDA-MB-231 cells MCT4 exhibited a Km for pyruvate of 4.2 mm, as opposed to >150 mm reported previously. Parallel assays with the pH-sensitive dye 2',7'-bis-(carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF) indicated that previous Km estimates based on substrate-induced acidification were severely biased by confounding pH-regulatory mechanisms. Numerical simulation using revised kinetic parameters revealed that MCT4, but not the related transporters MCT1 and MCT2, endows cells with the ability to export lactate in high-lactate microenvironments. In conclusion, MCT4 is a high-affinity lactate transporter with physiologically relevant affinity for pyruvate.
© 2019 Contreras-Baeza et al.

Entities:  

Keywords:  Michaelis-Menten; cancer; macrophage; metabolism; monocarboxylate transporter; pyruvate; transporter

Mesh:

Substances:

Year:  2019        PMID: 31719150      PMCID: PMC6937558          DOI: 10.1074/jbc.RA119.009093

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Non-Canonical Control of Neuronal Energy Status by the Na+ Pump.

Authors:  Felipe Baeza-Lehnert; Aiman S Saab; Robin Gutiérrez; Valeria Larenas; Esteban Díaz; Melanie Horn; Miriam Vargas; Ladina Hösli; Jillian Stobart; Johannes Hirrlinger; Bruno Weber; L Felipe Barros
Journal:  Cell Metab       Date:  2018-12-06       Impact factor: 27.287

2.  Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms.

Authors:  Victor Rusu; Eitan Hoch; Josep M Mercader; Danielle E Tenen; Melissa Gymrek; Christina R Hartigan; Michael DeRan; Marcin von Grotthuss; Pierre Fontanillas; Alexandra Spooner; Gaelen Guzman; Amy A Deik; Kerry A Pierce; Courtney Dennis; Clary B Clish; Steven A Carr; Bridget K Wagner; Monica Schenone; Maggie C Y Ng; Brian H Chen; Federico Centeno-Cruz; Carlos Zerrweck; Lorena Orozco; David M Altshuler; Stuart L Schreiber; Jose C Florez; Suzanne B R Jacobs; Eric S Lander
Journal:  Cell       Date:  2017-06-29       Impact factor: 41.582

3.  Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle.

Authors:  J E Manning Fox; D Meredith; A P Halestrap
Journal:  J Physiol       Date:  2000-12-01       Impact factor: 5.182

Review 4.  Bioenergetics and the problem of tumor growth.

Authors:  E Racker
Journal:  Am Sci       Date:  1972 Jan-Feb       Impact factor: 0.548

5.  Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines.

Authors:  Rajaa Hussien; George A Brooks
Journal:  Physiol Genomics       Date:  2010-12-21       Impact factor: 3.107

6.  Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70).

Authors:  Marieangela C Wilson; David Meredith; Jocelyn E Manning Fox; Christine Manoharan; Andrew J Davies; Andrew P Halestrap
Journal:  J Biol Chem       Date:  2005-05-24       Impact factor: 5.157

Review 7.  The Warburg Effect: How Does it Benefit Cancer Cells?

Authors:  Maria V Liberti; Jason W Locasale
Journal:  Trends Biochem Sci       Date:  2016-01-05       Impact factor: 13.807

Review 8.  Glucose and lactate supply to the synapse.

Authors:  L Felipe Barros; Joachim W Deitmer
Journal:  Brain Res Rev       Date:  2009-10-30

Review 9.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

10.  mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity.

Authors:  Shih-Chin Cheng; Jessica Quintin; Robert A Cramer; Kelly M Shepardson; Sadia Saeed; Vinod Kumar; Evangelos J Giamarellos-Bourboulis; Joost H A Martens; Nagesha Appukudige Rao; Ali Aghajanirefah; Ganesh R Manjeri; Yang Li; Daniela C Ifrim; Rob J W Arts; Brian M J W van der Veer; Brian M J W van der Meer; Peter M T Deen; Colin Logie; Luke A O'Neill; Peter Willems; Frank L van de Veerdonk; Jos W M van der Meer; Aylwin Ng; Leo A B Joosten; Cisca Wijmenga; Hendrik G Stunnenberg; Ramnik J Xavier; Mihai G Netea
Journal:  Science       Date:  2014-09-26       Impact factor: 47.728

View more
  33 in total

Review 1.  Metabolite transporters as regulators of macrophage polarization.

Authors:  Jingwen Cheng; Weiwei Cai; Shiye Zong; Yun Yu; Fang Wei
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-12-01       Impact factor: 3.000

2.  The histone deacetylase SIRT6 promotes glycolysis through the HIF-1α/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer.

Authors:  Qiai You; Jianmin Wang; Yongxin Yu; Feng Li; Lingxin Meng; Mingjing Chen; Qiao Yang; Zihan Xu; Jianguo Sun; Wenlei Zhuo; Zhengtang Chen
Journal:  Apoptosis       Date:  2022-08-01       Impact factor: 5.561

Review 3.  Dysregulation of immune checkpoint proteins in hepatocellular carcinoma: Impact on metabolic reprogramming.

Authors:  Kanchan Vishnoi; Sandeep Kumar; Rong Ke; Ajay Rana; Basabi Rana
Journal:  Curr Opin Pharmacol       Date:  2022-05-05       Impact factor: 4.768

4.  Role of monocarboxylate transporters in regulating metabolic homeostasis in the outer retina: Insight gained from cell-specific Bsg deletion.

Authors:  John Y S Han; Junzo Kinoshita; Sara Bisetto; Brent A Bell; Romana A Nowak; Neal S Peachey; Nancy J Philp
Journal:  FASEB J       Date:  2020-02-28       Impact factor: 5.191

Review 5.  Role of ZBTB7A zinc finger in tumorigenesis and metastasis.

Authors:  Atul Kumar Singh; Shiv Verma; Prem Prakash Kushwaha; Kumari Sunita Prajapati; Mohd Shuaib; Shashank Kumar; Sanjay Gupta
Journal:  Mol Biol Rep       Date:  2021-05-20       Impact factor: 2.316

Review 6.  The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells.

Authors:  Edward V Prochownik; Huabo Wang
Journal:  Cells       Date:  2021-03-30       Impact factor: 6.600

7.  Lactate sensing mechanisms in arterial chemoreceptor cells.

Authors:  Hortensia Torres-Torrelo; Patricia Ortega-Sáenz; Lin Gao; José López-Barneo
Journal:  Nat Commun       Date:  2021-07-06       Impact factor: 14.919

8.  Lactate dehydrogenase B regulates macrophage metabolism in the tumor microenvironment.

Authors:  Ann-Christin Frank; Rebecca Raue; Dominik C Fuhrmann; Evelyn Sirait-Fischer; Carsten Reuse; Andreas Weigert; Dieter Lütjohann; Karsten Hiller; Shahzad Nawaz Syed; Bernhard Brüne
Journal:  Theranostics       Date:  2021-06-04       Impact factor: 11.556

Review 9.  Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis.

Authors:  Ana Hipólito; Filipa Martins; Cindy Mendes; Filipa Lopes-Coelho; Jacinta Serpa
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

10.  HSPA12A unstabilizes CD147 to inhibit lactate export and migration in human renal cell carcinoma.

Authors:  Xinxu Min; Xiaojin Zhang; Yunfan Li; Xiaofei Cao; Hao Cheng; Yuehua Li; Chuanfu Li; Qiuyue Kong; Qian Mao; Peipei Peng; Yan Ni; Jingjin Li; Yulian Duan; Li Liu; Zhengnian Ding
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.